Terzapatide (Mounjaro) is a GLP-1/GIP dual agonist that combines effects of semaglutide (GLP-1 only) with additional GIP receptor activation, providing more potent glucose lowering and weight loss than GLP-1 monotherapy.

factualpending

Speaker

Dr. Kyle Gillette

Evidence Quote

“there's a combined glpgip that is terzapatide serves up a tide that's munjaro”

Source

Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauer
Created: 8/13/2026, 4:51:25 AM

Your notes

Loading notes...